Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Zimbus Breezhaler, indacaterol,glycopyrronium,mometasone furoate, Asthma, Date of authorisation: 03/07/2020, Revision: 4, Status: Authorised
TO: